Tag: neuromodulation
-
FDA Clears At-Home Neuromodulation Device for Major Depressive Disorder: Proliv™Rx
Overview: A new option for major depressive disorder The U.S. Food and Drug Administration (FDA) has cleared Proliv™Rx, an at-home neuromodulation device, for use as an adjunctive treatment for adults with major depressive disorder (MDD) who have not achieved satisfactory improvement after at least one previous therapy. This marks a notable milestone in the growing…
-
FDA Clears At-Home Neuromodulation Device for Major Depressive Disorder
FDA Clears At-Home Neuromodulation Device for Major Depressive Disorder The U.S. Food and Drug Administration has cleared Proliv™Rx, an at-home neuromodulation therapy, to be used as an adjunctive treatment for adults diagnosed with major depressive disorder (MDD) who have not achieved satisfactory improvement after at least one prior antidepressant. The approval marks a notable milestone…
-
Gated Associative Memory Networks: Robust Retrieval Beyond Critical Capacity
Why Gated Architectures Matter in Associative Memory Associative memory describes the brain’s remarkable ability to recover a complete pattern from incomplete information. Traditional models, inspired by Hebbian learning and classic attractor dynamics, often hit a hard limit known as the critical capacity. Beyond this point, recall becomes unreliable, and partial cues fail to reconstruct the…
-
Gated Associative Memory Networks Achieve Robust Retrieval Beyond Critical Capacity
Introduction Associative memory is a foundational concept in neuroscience and artificial intelligence: the ability to recall a complete pattern from partial cues. Recent work on gated associative memory networks shows that incorporating neuromodulation-inspired gating mechanisms can dramatically improve retrieval robustness, even when the system operates beyond its traditional critical capacity. This article explains how these…
-
New Frontiers in Treating Treatment-Resistant Depression: Vagus Nerve Stimulation and Beyond
Overview: The Rising Need for Neuromodulation in MDD Major depressive disorder (MDD) remains a global health challenge, with a significant subset of patients — up to 35% — not responding after four or more standard treatment trials. In the face of this treatment resistance, researchers and clinicians are turning to neuromodulation as a viable alternative…
-
Vagus Nerve Stimulation Offers Fresh Outlook for Treatment-Resistant Depression: Conference Report
Introduction: A Growing Challenge in Depression Care Major depressive disorder (MDD) remains a leading cause of disability worldwide. In a clinical landscape where up to 35% of patients do not respond to four or more standard treatments, researchers and clinicians are exploring innovative neuromodulation approaches. Vagus nerve stimulation (VNS) is gaining renewed attention as a…
-
Vagus Nerve Stimulation in TRD: New Lines of Thinking
Understanding the Crisis of Treatment-Resistant Depression Major depressive disorder (MDD) remains a leading cause of disability worldwide, and a substantial subset of patients fail to respond after multiple treatment attempts. Conference discussions centered on Vagus Nerve Stimulation (VNS) as a promising neuromodulation option for those with treatment-resistant depression (TRD). With up to 35% of patients…
-
Non-Surgical Therapeutic Brain Implants: A Future of Injected Precision Stimulation
Reimagining Brain Therapy: From Surgery to Injection Imagine a future where tiny electronic chips are placed in the brain not through invasive surgery, but via a simple injection in the arm. This is a vision researchers are actively exploring as they develop non-surgical therapeutic brain implants designed to electrically stimulate precise regions of the brain.…
-
Groundbreaking 4.4 Million Grant Funds First Study of Prefrontal Cortical Stimulation in Severe Bipolar Disorder
Overview of the Breakthrough Funding A University of Minnesota Medical School research team led by Dr. Ziad Nahas has secured a $4.4 million grant to launch the first-in-the-world study assessing prefrontal cortical stimulation as a treatment for severe bipolar disorder. The project, supported by Breakthrough Discoveries, marks a pivotal step in exploring innovative neuromodulation techniques…
-
Breakthrough Grant Advances First Study of Prefrontal Stimulation for Severe Bipolar Disorder
Groundbreaking Investment to Explore Neuromodulation in Bipolar Disorder A University of Minnesota Medical School research team, led by Dr. Ziad Nahas, has secured a $4.4 million grant to pursue a pioneering, first-in-the-world study of prefrontal cortical stimulation as a potential treatment for severe bipolar disorder. The funding comes from Breakthrough Discoveries, signaling strong confidence in…